126 related articles for article (PubMed ID: 36191672)
1. Pharmacokinetics of intact lipid nanocapsules using new quantitative FRET technique.
Lebreton V; Kaeokhamloed N; Vasylaki A; Hilairet G; Mellinger A; Béjaud J; Saulnier P; Lagarce F; Gattacceca F; Legeay S; Roger E
J Control Release; 2022 Nov; 351():681-691. PubMed ID: 36191672
[TBL] [Abstract][Full Text] [Related]
2. Elimination study of intact lipid nanocapsules after intravenous rat administration.
Lebreton V; Legeay S; Rapenne C; Saulnier P; Lagarce F
Nanomedicine (Lond); 2024 May; ():. PubMed ID: 38690778
[No Abstract] [Full Text] [Related]
3. Conventional versus stealth lipid nanoparticles: formulation and in vivo fate prediction through FRET monitoring.
Lainé AL; Gravier J; Henry M; Sancey L; Béjaud J; Pancani E; Wiber M; Texier I; Coll JL; Benoit JP; Passirani C
J Control Release; 2014 Aug; 188():1-8. PubMed ID: 24878182
[TBL] [Abstract][Full Text] [Related]
4. Inter-nanocarrier and nanocarrier-to-cell transfer assays demonstrate the risk of an immediate unloading of dye from labeled lipid nanocapsules.
Simonsson C; Bastiat G; Pitorre M; Klymchenko AS; Béjaud J; Mély Y; Benoit JP
Eur J Pharm Biopharm; 2016 Jan; 98():47-56. PubMed ID: 26522878
[TBL] [Abstract][Full Text] [Related]
5. FRET imaging approaches for in vitro and in vivo characterization of synthetic lipid nanoparticles.
Gravier J; Sancey L; Hirsjärvi S; Rustique E; Passirani C; Benoît JP; Coll JL; Texier I
Mol Pharm; 2014 Sep; 11(9):3133-44. PubMed ID: 25098740
[TBL] [Abstract][Full Text] [Related]
6. Fate of paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery.
Groo AC; Saulnier P; Gimel JC; Gravier J; Ailhas C; Benoit JP; Lagarce F
Int J Nanomedicine; 2013; 8():4291-302. PubMed ID: 24235827
[TBL] [Abstract][Full Text] [Related]
7. A Copper-Mediated Disulfiram-Loaded pH-Triggered PEG-Shedding TAT Peptide-Modified Lipid Nanocapsules for Use in Tumor Therapy.
Zhang L; Tian B; Li Y; Lei T; Meng J; Yang L; Zhang Y; Chen F; Zhang H; Xu H; Zhang Y; Tang X
ACS Appl Mater Interfaces; 2015 Nov; 7(45):25147-61. PubMed ID: 26501354
[TBL] [Abstract][Full Text] [Related]
8. Praziquantel-lipid nanocapsules: an oral nanotherapeutic with potential
Amara RO; Ramadan AA; El-Moslemany RM; Eissa MM; El-Azzouni MZ; El-Khordagui LK
Int J Nanomedicine; 2018; 13():4493-4505. PubMed ID: 30122922
[TBL] [Abstract][Full Text] [Related]
9. Intranasal lipid nanocapsules for systemic delivery of nimodipine into the brain: In vitro optimization and in vivo pharmacokinetic study.
Mohsen K; Azzazy HME; Allam NK; Basalious EB
Mater Sci Eng C Mater Biol Appl; 2020 Nov; 116():111236. PubMed ID: 32806316
[TBL] [Abstract][Full Text] [Related]
10. Model Affitin and PEG modifications onto siRNA lipid nanocapsules: cell uptake and
Resnier P; Lepeltier E; Emina AL; Galopin N; Bejaud J; David S; Ballet C; Benvegnu T; Pecorari F; Chourpa I; Benoit JP; Passirani C
RSC Adv; 2019 Aug; 9(47):27264-27278. PubMed ID: 35529231
[TBL] [Abstract][Full Text] [Related]
11. Treatment of 9L gliosarcoma in rats by ferrociphenol-loaded lipid nanocapsules based on a passive targeting strategy via the EPR effect.
Huynh NT; Morille M; Bejaud J; Legras P; Vessieres A; Jaouen G; Benoit JP; Passirani C
Pharm Res; 2011 Dec; 28(12):3189-98. PubMed ID: 21691892
[TBL] [Abstract][Full Text] [Related]
12. Enhanced oral bioavailability of Tanshinone IIA using lipid nanocapsules: Formulation, in-vitro appraisal and pharmacokinetics.
Ashour AA; Ramadan AA; Abdelmonsif DA; El-Kamel AH
Int J Pharm; 2020 Aug; 586():119598. PubMed ID: 32629068
[TBL] [Abstract][Full Text] [Related]
13. New In Vitro Coculture Model for Evaluating Intestinal Absorption of Different Lipid Nanocapsules.
Kaeokhamloed N; Roger E; Béjaud J; Lautram N; Manero F; Perrot R; Abbara C; Briet M; Legeay S
Pharmaceutics; 2021 Apr; 13(5):. PubMed ID: 33919334
[TBL] [Abstract][Full Text] [Related]
14. Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting.
Morille M; Montier T; Legras P; Carmoy N; Brodin P; Pitard B; Benoît JP; Passirani C
Biomaterials; 2010 Jan; 31(2):321-9. PubMed ID: 19800113
[TBL] [Abstract][Full Text] [Related]
15. Lipid nanocapsules maintain full integrity after crossing a human intestinal epithelium model.
Roger E; Gimel JC; Bensley C; Klymchenko AS; Benoit JP
J Control Release; 2017 May; 253():11-18. PubMed ID: 28274740
[TBL] [Abstract][Full Text] [Related]
16. Ultra-small-size Astragaloside-IV loaded lipid nanocapsules eye drops for the effective management of dry age-related macular degeneration.
Sun R; Zhang A; Ge Y; Gou J; Yin T; He H; Wang Y; Zhang G; Kong J; Shang L; Tao X; Zhang Y; Tang X
Expert Opin Drug Deliv; 2020 Sep; 17(9):1305-1320. PubMed ID: 32538226
[TBL] [Abstract][Full Text] [Related]
17. Lipid nanocapsules as a new delivery system in copepods: Toxicity studies and optical imaging.
Stancheva S; Souissi A; Ibrahim A; Barras A; Spriet C; Souissi S; Boukherroub R
Colloids Surf B Biointerfaces; 2015 Nov; 135():441-447. PubMed ID: 26280818
[TBL] [Abstract][Full Text] [Related]
18. Polymeric versus lipid nanocapsules for miconazole nitrate enhanced topical delivery:
Abdel-Rashid RS; Helal DA; Alaa-Eldin AA; Abdel-Monem R
Drug Deliv; 2022 Dec; 29(1):294-304. PubMed ID: 35037528
[TBL] [Abstract][Full Text] [Related]
19. Inner ear biocompatibility of lipid nanocapsules after round window membrane application.
Zhang Y; Zhang W; Löbler M; Schmitz KP; Saulnier P; Perrier T; Pyykkö I; Zou J
Int J Pharm; 2011 Feb; 404(1-2):211-9. PubMed ID: 21075187
[TBL] [Abstract][Full Text] [Related]
20. In vivo evaluation of paclitaxel-loaded lipid nanocapsules after intravenous and oral administration on resistant tumor.
Groo AC; Bossiere M; Trichard L; Legras P; Benoit JP; Lagarce F
Nanomedicine (Lond); 2015 Mar; 10(4):589-601. PubMed ID: 25723092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
